X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (87) 87
humans (85) 85
hiv infections - drug therapy (75) 75
infectious diseases (66) 66
once-daily darunavir/ritonavir (66) 66
hiv (52) 52
human immunodeficiency virus--hiv (48) 48
antiretroviral drugs (46) 46
pharmacology & pharmacy (46) 46
darunavir (44) 44
antiretroviral therapy (43) 43
safety (43) 43
efficacy (41) 41
drug therapy (40) 40
hiv infection (40) 40
female (38) 38
immunology (37) 37
male (37) 37
protease inhibitors (37) 37
adult (36) 36
virology (36) 36
double-blind (35) 35
naive hiv-1-infected patients (35) 35
ritonavir (33) 33
anti-hiv agents - therapeutic use (32) 32
treatment-naive (30) 30
hiv infections - virology (29) 29
hiv-1 - drug effects (29) 29
anti-hiv agents - administration & dosage (28) 28
treatment outcome (28) 28
hiv-1-infected patients (27) 27
antiviral agents (25) 25
middle aged (25) 25
twice-daily lopinavir/ritonavir (25) 25
drug therapy, combination (24) 24
highly active antiretroviral therapy (24) 24
once-daily dolutegravir (24) 24
treatment-experienced patients (24) 24
cd4 lymphocyte count (22) 22
initial treatment (22) 22
dolutegravir (21) 21
hiv-1 (21) 21
pharmacokinetics (21) 21
ritonavir - administration & dosage (21) 21
clinical trials (20) 20
pharmacology (20) 20
acquired immune deficiency syndrome--aids (19) 19
active antiretroviral therapy (19) 19
hiv-infected patients (19) 19
raltegravir (19) 19
viral load (19) 19
hiv protease inhibitors - therapeutic use (18) 18
lopinavir/ritonavir (18) 18
once-daily atazanavir/ritonavir (18) 18
protease inhibitor (18) 18
antiretroviral-naive adults (17) 17
patients (17) 17
ritonavir - therapeutic use (17) 17
antiretroviral agents (16) 16
dosage and administration (16) 16
lopinavir (16) 16
research (16) 16
sulfonamides - therapeutic use (16) 16
tenofovir (16) 16
tenofovir disoproxil fumarate (16) 16
aids/hiv (15) 15
drug administration schedule (15) 15
emtricitabine (15) 15
hiv protease inhibitors - administration & dosage (15) 15
medicine (15) 15
analysis (14) 14
anti-hiv agents - adverse effects (14) 14
antiretroviral therapy, highly active - methods (14) 14
co-formulated elvitegravir (14) 14
mutation (14) 14
non-inferiority trial (14) 14
proteinase inhibitors (14) 14
reverse-transcriptase inhibitors (14) 14
sulfonamides - administration & dosage (14) 14
aids (13) 13
drug combinations (13) 13
drug resistance (13) 13
efavirenz (13) 13
medicine, general & internal (13) 13
microbiology (13) 13
studies (13) 13
young adult (13) 13
atazanavir (12) 12
care and treatment (12) 12
drug interactions (12) 12
drug resistance, viral (12) 12
health aspects (12) 12
lamivudine (12) 12
ritonavir - adverse effects (12) 12
therapy (12) 12
combination (11) 11
drug-resistance (11) 11
hiv infections - immunology (11) 11
hiv protease inhibitors - adverse effects (11) 11
human immunodeficiency virus (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
AIDS, ISSN 0269-9370, 11/2011, Volume 25, Issue 17, pp. 2113 - 2122
Objective: To explore darunavir/ritonavir (DRV/r) plus raltegravir (RAL) combination therapy in antiretroviral-naive patients. Design: Phase IIb, single-arm,... 
INFECTIOUS DISEASES | SAFETY | antiretroviral therapy | nucleoside sparing | raltegravir | INITIAL TREATMENT | IMMUNOLOGY | COMBINATION | VIROLOGY | HIV-1 VIRAL LOAD | ANTIRETROVIRAL DRUG-RESISTANCE | darunavir | LOPINAVIR/RITONAVIR | INFECTION | ONCE-DAILY DARUNAVIR/RITONAVIR | TENOFOVIR
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 10/2018, Volume 37, Issue 10, pp. 1008 - 1010
In this multicenter pharmacokinetic study in HIV-infected children (6–12 years of age), we validated the approved once-daily darunavir/ritonavir dosing... 
INFECTIOUS DISEASES | HIV | children | DRUGS | pharmacokinetics | PEDIATRICS | darunavir | IMMUNOLOGY | once-daily | Pharmaceutical research | Darunavir | Ritonavir | Patient outcomes | HIV infection in children | Dosage and administration | Research | Pharmacokinetics | Drug therapy
Journal Article
AIDS, ISSN 0269-9370, 09/2009, Volume 23, Issue 14, pp. 1829 - 1840
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 05/2013, Volume 85, Issue 5, pp. 755 - 759
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2011, Volume 16, Issue 1, pp. 99 - 108
Background: In the Phase III ARTEMIS Trial, treatment-naive patients received once-daily darunavir/ritonavir (DRV/r) 800/100 mg (n=343) or lopinavir/ritonavir... 
INFECTIOUS DISEASES | HIV-1-INFECTED PATIENTS | ANTIRETROVIRAL THERAPY | DRUG-RESISTANCE | ADHERENCE | HIV-INFECTED PATIENTS | RESPONSES | TREATMENT-NAIVE | VIROLOGY | PHARMACOLOGY & PHARMACY | SOCIETY-USA PANEL | 2008 RECOMMENDATIONS | ONCE-DAILY DARUNAVIR/RITONAVIR
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 05/2016, Volume 10, pp. 1589 - 1603
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e60814
Journal Article
Journal Article